Union Budget 2025: Pharma industry applauds key provisions on drug accessibility, R&D boost Read more
Bolstering India’s healthcare innovation in cancer, rare diseases: How Budget 2025 can make a difference? Read more
Pharma sector gears up for Budget 2025-26; urges for strong regulatory framework and faster approval pathways Read more
Immuneel Therapeutics presents early data from India for Varnimcabtagene autoleucel at ASH Annual Meeting 2022 Read more
Immuneel sets up cell therapy development and production facility in Narayana Hrudayalaya Health City, Bengaluru Read more
Immuneel, HCB and IDIBAPS enter into a collaboration and licensing agreement for CAR T cell therapy Read more
